Investigating the Clinical Utility of the MDS

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Skin LesionMelanomaMoles
Interventions
DIAGNOSTIC_TEST

Melanoma Detection System -MDS

Imaging of lesion using the MDS test.

Trial Locations (1)

ML60JS

NHS Lanarkshire, Monklands Hospital, Airdrie

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

NHS Lanarkshire

OTHER_GOV

collaborator

NHS Tayside

OTHER_GOV

collaborator

NHS Greater Glasgow and Clyde

OTHER

collaborator

University Hospitals, Leicester

OTHER

collaborator

University of Dundee

OTHER

lead

Orlucent, Inc

INDUSTRY

NCT03109327 - Investigating the Clinical Utility of the MDS | Biotech Hunter | Biotech Hunter